Peter De Cruz (P De Cruz)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 14

Top Topics

Ulcerative Colitis

Top Venues

Alimentary pharmacology & therapeutics

Inflammatory bowel diseases

Journal of gastroenterology and hepatology

Journal of medical Internet research

This page only lists publications with an associated author ORCID identifier.

Publications

Patrick Hilley, Darren J Wong, Peter De Cruz
How Does an Integrated Pharmacist Add Value in the Management of Inflammatory Bowel Disease in the Era of Values-Based Healthcare? Inflammatory bowel diseases (2024)
Simone Chin, Lucy Fox, Avik Majumdar, Mark Oliver, Matthew C Choy, Peter De Cruz
Pneumocystis jirovecii Pneumonia Complicating Use of Upadacitinib in a Patient With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Case Report. Inflammatory bowel diseases 30 (8) (2024)
Simone Chin, Lucy Fox, Avik Majumdar, Mark Oliver, Matthew C Choy, Peter De Cruz
Pneumocystis jirovecii Pneumonia Complicating Use of Upadacitinib in a Patient With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Case Report. Inflammatory bowel diseases (2024)
Abhinav Vasudevan, Danny Con, Peter De Cruz, Miles Patrick Sparrow, Antony B Friedman, Mayur Garg, Soleiman Kashkooli, Peter R Gibson, Daniel R Van Langenberg
Clinical trial: Combination allopurinol-thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study). Alimentary pharmacology & therapeutics (2023)
Christopher F D Li Wai Suen, Dean Seah, Matthew C Choy, Peter De Cruz
Factors Associated With Response to Rescue Therapy in Acute Severe Ulcerative Colitis. Inflammatory bowel diseases (2023)
Ashish Srinivasan, Peter De Cruz, Melissa Sam, Catherine Toong, Daniel R Van Langenberg
Dose intensification strategy influences infliximab pharmacokinetics but not clinical response after the same number of doses. Journal of gastroenterology and hepatology (2023)
Ashish Srinivasan, Peter De Cruz, Melissa Sam, Catherine Toong, Daniel R Van Langenberg
Dose intensification strategy influences infliximab pharmacokinetics but not clinical response after the same number of doses. Journal of gastroenterology and hepatology (2023)
Andrew H Kim, Afaf Girgis, Peter De Cruz, Corey Allan Siegel, Neda Karimi, Sasha O Ruban, Alexandra J Sechi, Wa Sang Watson Ng, Jane M Andrews, Susan J Connor
Development and Feasibility of a Web-Based Decision Aid for Patients With Ulcerative Colitis: Qualitative Pilot Study. Journal of medical Internet research 23 (2) (2021)
Emma K Flanagan, Peter R Gibson, Emily K Wright, Gregory T Moore, Miles Patrick Sparrow, William Connell, Michael A Kamm, Jakob Begun, Britt Christensen, Peter De Cruz, Edward Shelton, Damian Dowling, Jane M Andrews, Steven J Brown, Olga D Niewiadomski, Mark G Ward, Ourania Rosella, Gennaro Rosella, Katerina V Kiburg, Alyson L Ross, Sally J Bell, null null
Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure. Alimentary pharmacology & therapeutics 52 (10) (2020)
Christopher F D Li Wai Suen, Matthew C Choy, Peter De Cruz
Letter: infliximab induction regimens in steroid-refractory acute severe colitis-a propensity score analysis. Alimentary pharmacology & therapeutics 51 (6) (2020)
Christopher F D Li Wai Suen, Matthew C Choy, Peter De Cruz
Letter: how can we reduce mortality in elderly patients with acute severe ulcerative colitis? Alimentary pharmacology & therapeutics 51 (12) (2020)
Belinda D Jackson, Jake Begun, Kathleen Gray, Leonid Churilov, Danny Liew, Simon Robert Knowles, Peter De Cruz
Clinical decision support improves quality of care in patients with ulcerative colitis. Alimentary pharmacology & therapeutics 49 (8) (2019)
Matthew C Choy, Peter De Cruz
Letter: dose optimising infliximab in acute severe ulcerative colitis. Alimentary pharmacology & therapeutics 45 (8) (2017)
Danny Con, Peter De Cruz
Mobile Phone Apps for Inflammatory Bowel Disease Self-Management: A Systematic Assessment of Content and Tools. JMIR mHealth and uHealth 4 (1) (2016)